JPH10165428A - Implant for medical treatment - Google Patents

Implant for medical treatment

Info

Publication number
JPH10165428A
JPH10165428A JP33597996A JP33597996A JPH10165428A JP H10165428 A JPH10165428 A JP H10165428A JP 33597996 A JP33597996 A JP 33597996A JP 33597996 A JP33597996 A JP 33597996A JP H10165428 A JPH10165428 A JP H10165428A
Authority
JP
Japan
Prior art keywords
implant
tissue
disease
current
apatite
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP33597996A
Other languages
Japanese (ja)
Inventor
Katsunari Nishihara
克成 西原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP33597996A priority Critical patent/JPH10165428A/en
Publication of JPH10165428A publication Critical patent/JPH10165428A/en
Pending legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To provide an implant to be implanted in a living body for treatment of a disease by reinforcing immunity. SOLUTION: This implant for treatment of a disease is to be implanted inside a produced tissue to make undifferent mesenchymal cells differentiate by electric currents. Specifically, such an implant that can supply electric currents to the produced tissue with an electric density between 10mA/cm<2> -50mA /cm<2> , or an implant made of apatite is used.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、生物の体内に埋設
して、その作用で免疫を補充することにより病気治療に
用いるインプラントに関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an implant which is used for treating diseases by being buried in the body of an organism and replenishing immunity by its action.

【0002】[0002]

【従来の技術】放射能を浴びる事故などによって白血病
となり、または造血組織に癌が発生するなどの病変で、
造血組織を除去しなければならなくなった患者を治療す
るには、血液型が正確に一致する健康な人をさがしだ
し、この人の骨髄から造血組織を一部抽出して患者の骨
髄に移植することが必要とされる。この際に血液型が正
確に一致する人を探し出すことは容易ではなく、そのた
めに現状ではこの移植手術ができないまま死亡する例が
多い。この例のように患者が病気によって失った機能を
補うために他人の組織を利用すれば治癒を期待できる場
合があるが、その際には血液型の正確な一致が必要であ
る。しかし、血液型は多数あって、その正確な一致は親
子の関係でも必ずしも期待できない事情にあり、その実
行は困難であることが多い。
2. Description of the Related Art Leukemia is caused by an accident such as exposure to radioactivity, or a lesion such as the occurrence of cancer in hematopoietic tissue.
To treat a patient who has to remove hematopoietic tissue, find a healthy person whose blood type matches exactly and extract some of the hematopoietic tissue from this person's bone marrow and transplant it into the patient's bone marrow. Is needed. In this case, it is not easy to find a person whose blood type is exactly the same. In some cases, healing can be expected by using the tissue of another person to supplement the function lost by the disease, as in this example, but this requires accurate matching of blood types. However, there are many blood types, and the exact agreement is not always expected even in a parent-child relationship, and its implementation is often difficult.

【0003】[0003]

【発明が解決しようとする課題】もし、患者本人の体の
組織を用いて患者が失った機能を再生させることができ
れば、他人から造血組織をもらうことが必要ではなくな
り、血液型の問題はなくなる。生物体は細胞から構成さ
れ、その各細胞は遺伝子を有していて、その遺伝子には
その生体物を特徴付ける情報が完全な形で納められてい
ることは良く知られている。したがって、もしこの遺伝
情報を充分に発現させることができれば、患者自身の健
康な組織を再現して失われた機能を補完できる筈であ
る。しかし、現実には高等な生物体を構成する各細胞は
通常高度に分化している。その細胞が保有する遺伝情報
は高度に分化した状態の範囲でのみ発現されるから、失
われた機能を担っていた組織の細胞が失われてしまえ
ば、その補完はできない。そのため、生物の各細胞が本
来保有する遺伝情報を充分に発揮させることにより、失
われた機能を再生することは、蟹の足やトカゲの尻尾の
再生では実現されるが哺乳類などの高等な生物では不可
能であるとされている。
If the function lost by the patient can be reproduced by using the tissue of the patient's own body, it is not necessary to obtain hematopoietic tissue from another person, and the problem of blood type disappears. . It is well known that an organism is composed of cells, and each cell has a gene, and the gene contains complete information that characterizes the organism. Therefore, if this genetic information can be fully expressed, it should be possible to reproduce the patient's own healthy tissue and complement the lost function. However, in reality, each cell constituting a higher organism is usually highly differentiated. Since the genetic information held by the cells is expressed only in a highly differentiated state, once the cells of the tissue that had lost the function are lost, the complementation cannot be made. Therefore, regeneration of the lost function by fully utilizing the genetic information originally possessed by each cell of the organism can be achieved by regeneration of crab feet and lizard tails, but it can be achieved by advanced organisms such as mammals. Is said to be impossible.

【0004】本発明では、この失われた機能の再生が、
どの程度まで可能であるかを検討することによって、患
者本人の体の組織を用いて患者が失った機能を再生させ
る手段を提供しようとするものである。
In the present invention, reproduction of this lost function is
By examining the extent to which it is possible, it seeks to provide a means for using the patient's own body tissue to regenerate the functions that the patient has lost.

【0005】[0005]

【課題を解決するための手段】本発明は、生体組織内に
埋設し、未分化間葉系細胞の分化を電流によって誘起せ
しめることを特徴とする病気治療用インプラントであ
る。
SUMMARY OF THE INVENTION The present invention is an implant for disease treatment which is embedded in a living tissue and induces the differentiation of undifferentiated mesenchymal cells by electric current.

【0006】高等な生物でも、傷を受ければその傷の治
療に際して未分化の間葉系細胞は多数発生し、これが傷
の治療に関係していることが知られている。本発明者
は、手術で生物組織を切開する際に多数生じる未分化間
葉系細胞に電流を付加することにより、細胞が本来保有
する遺伝情報の発現を誘導することが可能であることを
見出し、この現象を利用することによって、失われた組
織を再生させ、機能の回復を計る治療法を開発し、これ
に必要なインプラントが本発明である。
[0006] Even in higher organisms, it is known that, when a wound is treated, a large number of undifferentiated mesenchymal cells are generated during the treatment of the wound, and this is related to the treatment of the wound. The present inventor has found that it is possible to induce the expression of genetic information originally held by cells by applying a current to undifferentiated mesenchymal cells generated a lot when incising biological tissue by surgery. By utilizing this phenomenon, a therapeutic method for regenerating lost tissue and restoring function is developed, and the implant necessary for this is the present invention.

【0007】より具体的には、10mA/cm2以上5
0mA/cm2以下の電流密度で生体組織に電流を流し
得る構造を有し、これを用いて生体組織内に電流を流す
ことによって効果を発現させるものである。上記の電流
密度範囲が細胞の本来保有する遺伝情報の発現を誘導す
るに最も適した範囲であることが、多くの試験により確
認された。又、アパタイトを主要な構成要素とするイン
プラントであって、血液がそのアパタイト製インプラン
トと接触して流動することにより流動電位が発生し、こ
の電位によって電流が生成組織内を流れる構造を有して
おり、生体組織に埋設して用いるものである。
More specifically, 10 mA / cm 2 or more 5
It has a structure that allows a current to flow through a living tissue at a current density of 0 mA / cm 2 or less, and an effect is exhibited by flowing a current through the living tissue using the structure. Many tests have confirmed that the above-mentioned current density range is the most suitable range for inducing the expression of genetic information inherent in cells. In addition, an implant having apatite as a main component, has a structure in which blood flows in contact with the apatite implant to generate a streaming potential, and the potential causes a current to flow through the generated tissue. And embedded in living tissue for use.

【0008】例えばチタン金属又は白金で作られた電極
を生物組織内に埋め込み、これに電流を流すと造血組織
が電極周辺に生成する。この造血組織をその生物の骨髄
に移植すると健全な機能を有する造血組織が再生でき
る。
[0008] An electrode made of, for example, titanium metal or platinum is embedded in biological tissue, and when an electric current is applied to the electrode, hematopoietic tissue is generated around the electrode. When this hematopoietic tissue is transplanted into the bone marrow of the organism, hematopoietic tissue having a healthy function can be regenerated.

【0009】同様の効果は、アパタイト成形体を生物組
織内に埋め込み、豊富な血流がアパタイトに接するよう
にすると流動電位が発生し、電流を外部から流したと同
様にアパタイト周辺に造血組織が生成する。この造血組
織をその生物体の造血組織が失われた骨髄に移植すると
健全な機能を有する造血組織が再生できる。
[0009] The same effect is obtained by embedding an apatite molded body in a biological tissue so that abundant blood flow comes into contact with the apatite, a streaming potential is generated, and a hematopoietic tissue is formed around the apatite in the same manner as when an electric current is applied from the outside. Generate. When this hematopoietic tissue is transplanted into bone marrow from which the hematopoietic tissue of the organism has been lost, hematopoietic tissue having a healthy function can be regenerated.

【0010】[0010]

【発明の実施の形態】以下、本発明を実施例に基づいて
説明する。
DESCRIPTION OF THE PREFERRED EMBODIMENTS Hereinafter, the present invention will be described based on embodiments.

【0011】実施例1 図1において1はボタン型の銀電池であり、導線2,3
を介して電極4に接続する。5は電気抵抗で10MΩか
ら10kΩの範囲とした。電池1の起電圧は1.55V
である。電極4は、径0.3mm、長さ1064mmの
チタン金属線を繰り返し周期1mmのサイン曲線を描く
ように曲げた後、円柱様の押型に入れ圧縮することによ
り、チタン金属線塊の外形が径7mm、高さ5mmの円
柱となるように成形したものである。電池1、導線2、
電極3の基部および抵抗5は電気絶縁性合成樹脂6をも
って被覆保護する。このようにして得たものは、チタン
金属線塊からなる電極は金属線の間に約0.2〜0.4
mm程度の細かい隙間が電極全体にほぼ一様に分布した
多孔体となっている。このためにこの電極の隙間を液体
が自由に流通するようになっている。
Embodiment 1 In FIG. 1, reference numeral 1 denotes a button-type silver battery,
Is connected to the electrode 4 via. Reference numeral 5 denotes an electric resistance in a range from 10 MΩ to 10 kΩ. The electromotive voltage of the battery 1 is 1.55V
It is. The electrode 4 was formed by repeatedly bending a titanium metal wire having a diameter of 0.3 mm and a length of 1064 mm so as to draw a sine curve with a period of 1 mm, and then compressing the metal wire into a cylindrical mold to reduce the outer shape of the titanium metal wire block. It is molded so as to be a cylinder having a height of 7 mm and a height of 5 mm. Battery 1, lead 2,
The base of the electrode 3 and the resistor 5 are covered and protected by an electrically insulating synthetic resin 6. The electrode obtained from the titanium metal wire lump was about 0.2 to 0.4 between the metal wires.
It is a porous body in which fine gaps of about mm are distributed almost uniformly throughout the electrode. For this reason, the liquid freely flows through the gap between the electrodes.

【0012】かかる人工免疫器官を造血機能に欠陥を持
つ犬の筋肉組織内に埋設し、約2週間経過すると、上記
抵抗値のいずれの場合でも造血組織が電極4の周辺に生
成し、電極は造血組織の中に埋まった形となった。これ
によって得られた造血組織をこの犬の骨髄に移植すると
正常な造血が行われ、移植前には正常ではなかった造血
機能が正常に回復したことが確認できた。
When such an artificial immune organ is buried in the muscle tissue of a dog having a defective hematopoietic function, and after about two weeks, the hematopoietic tissue is generated around the electrode 4 regardless of the above resistance value, and the electrode is It became buried in hematopoietic tissue. When hematopoietic tissue thus obtained was transplanted into the bone marrow of this dog, normal hematopoiesis was performed, and it was confirmed that hematopoietic functions, which were not normal before transplantation, were restored to normal.

【0013】又、図1において電池1を集積回路からな
る交流発生装置に差し替えることにより、生体組織に交
流電流を付加する実験を試みた。その周波数を1Hzか
ら1kHzまで変えたが、その結果は上記の電池を用い
た際の結果と全く同様で、電極周辺に正常な造血組織が
生成した。
Further, an experiment was conducted in which an alternating current was applied to a living tissue by replacing the battery 1 with an alternating current generator composed of an integrated circuit in FIG. The frequency was changed from 1 Hz to 1 kHz. The result was exactly the same as the result when the above-mentioned battery was used, and a normal hematopoietic tissue was formed around the electrode.

【0014】実施例2 アパタイト焼結体からなる成形体で数ミリ角から数セン
チ角の長方体や円柱、円筒などを単に犬の背筋内に埋設
して3ケ月程度経過すると造血組織がこのアパタイト成
形体周辺に生成する。このようにして得られる造血組織
をこの犬の骨髄に移植しても実施例1と同様の効果を得
ることができた。
Example 2 A rectangular body, a cylinder, a cylinder, or the like having a size of several millimeters to several centimeters is simply buried in the back muscle of a dog in a compact made of an apatite sintered body. Generated around the apatite compact. Even if the hematopoietic tissue thus obtained was transplanted into the bone marrow of this dog, the same effect as in Example 1 could be obtained.

【0015】[0015]

【発明の効果】本発明のインプラントは免疫器官として
生物の体内に埋設することによって、免疫の中軸を担う
正常な造血組織を発生する。この正常な造血組織を用い
ることによりその生物の健康を回復できる。
The implant of the present invention generates a normal hematopoietic tissue which plays a central role in immunity by being embedded in an organism as an immune organ. Use of this normal hematopoietic tissue can restore the health of the organism.

【図面の簡単な説明】[Brief description of the drawings]

【図1】本発明の実施例の説明図である。FIG. 1 is an explanatory diagram of an embodiment of the present invention.

【符号の説明】[Explanation of symbols]

1 銀電池 2,3 導線 4 電極 5 電気抵抗 6 電気絶縁性合成樹脂 DESCRIPTION OF SYMBOLS 1 Silver battery 2, 3 Conductor wire 4 Electrode 5 Electric resistance 6 Electric insulating synthetic resin

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 生成組織内に埋設し、未分化間葉系細胞
の分化を電流によって誘起せしめることを特徴とする病
気治療用インプラント。
1. An implant for treating a disease, which is embedded in a producing tissue and induces differentiation of undifferentiated mesenchymal cells by electric current.
【請求項2】 10mA/cm2以上50mA/cm2
下の電流密度で生体組織に電流を流し得る構造を有し、
これを用いて生成組織内に電流を流すことによって効果
を発現させることを特徴とする病気治療用インプラン
ト。
2. A structure capable of passing a current to a living tissue at a current density of 10 mA / cm 2 or more and 50 mA / cm 2 or less,
An implant for treating a disease, characterized in that an effect is produced by flowing an electric current into a producing tissue using the same.
【請求項3】 アパタイトを主要な構成要素とするイン
プラントであって、血液がそのアパタイト製インプラン
トと接触して流動することにより流動電位が発生し、こ
の電位によって電流が生成組織内を流れる構造を有して
おり、生成組織に埋設して用いることを特徴とする病気
治療用インプラント。
3. An implant containing apatite as a main component, wherein blood flows in contact with the apatite implant to generate a streaming potential, and the potential causes a current to flow through a generating tissue. An implant for treating a disease, which is used by being embedded in a production tissue.
JP33597996A 1996-12-16 1996-12-16 Implant for medical treatment Pending JPH10165428A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP33597996A JPH10165428A (en) 1996-12-16 1996-12-16 Implant for medical treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP33597996A JPH10165428A (en) 1996-12-16 1996-12-16 Implant for medical treatment

Publications (1)

Publication Number Publication Date
JPH10165428A true JPH10165428A (en) 1998-06-23

Family

ID=18294448

Family Applications (1)

Application Number Title Priority Date Filing Date
JP33597996A Pending JPH10165428A (en) 1996-12-16 1996-12-16 Implant for medical treatment

Country Status (1)

Country Link
JP (1) JPH10165428A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003038031A1 (en) * 2001-10-31 2003-05-08 Hakuju Institute For Health Science Co., Ltd. Cell culturing system and method for measuring dose response

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003038031A1 (en) * 2001-10-31 2003-05-08 Hakuju Institute For Health Science Co., Ltd. Cell culturing system and method for measuring dose response

Similar Documents

Publication Publication Date Title
Clark The multiple-channel cochlear implant: the interface between sound and the central nervous system for hearing, speech, and language in deaf people—a personal perspective
Clark et al. The histopathology of the human temporal bone and auditory central nervous system following cochlear implantation in a patient: correlation with psychophysics and speech perception results
Shepherd et al. Chronic electrical stimulation of the auditory nerve in cats: physiological and histopathological results
Becker The bioelectric factors in amphibian-limb regeneration
US4105017A (en) Modification of the growth repair and maintenance behavior of living tissue and cells by a specific and selective change in electrical environment
Rubinstein et al. Signal coding in cochlear implants: exploiting stochastic effects of electrical stimulation
EP3393573A1 (en) Transcranial electrical stimulation device having multipurpose electrodes
CN108525124A (en) Through cranium galvanic current stimulation equipment
CN108348762A (en) Dentistry external member
Crow et al. Controlled multifocal frontal leucotomy for psychiatric illness
Liang et al. The nerve-electrode interface of the cochlear implant: current spread
CN106139388A (en) A kind of nerve electrode and preparation method thereof
Clark A hearing prosthesis for serve perceptive Deafness—Experimental studies
JPH10165428A (en) Implant for medical treatment
US6181962B1 (en) Electrically activated substance and method for making the same
Merzenich et al. Cochlear implant prostheses: Strategies and progress
Abbas et al. The neurophysiological effects of simulated auditory prosthesis stimulation
CN106422059A (en) Control method and device of transcranial direct current stimulation system
EP3824944A1 (en) Plate electrodes
Girasoli et al. First Electrical Stimulations of the Ear with Voltaic Pile (Letter by Professor Volta to Professor Brugnatelli," Above the Application of Electricity to Deaf-Mutes from Birth").
Morton " Cataphoresis"; Or, Electric Medicamental Diffusion: As Applied in Medicine, Surgery and Dentistry
US20230059692A1 (en) Ultrasonic powered neural stimulating device without power sources and lead wires
JPH02107229A (en) Electrode
Cumberbatch Essentials of medical electricity
AU752905B2 (en) Electrically activated substance and method for making same

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060605

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20061106